Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.

Lund N, Wieboldt H, Fischer L, Muschol N, Braun F, Huber T, Sorriento D, Iaccarino G, Müllerleile K, Tahir E, Adam G, Kirchhof P, Fabritz L, Patten M

Open source

DOI
10.3389/fcvm.2024.1355033
Published
2024
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2024.1355033,
  title = {Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.},
  author = {Lund N and Wieboldt H and Fischer L and Muschol N and Braun F and Huber T and Sorriento D and Iaccarino G and Müllerleile K and Tahir E and Adam G and Kirchhof P and Fabritz L and Patten M},
  year = {2024},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2024.1355033},
  url = {https://doi.org/10.3389/fcvm.2024.1355033}
}

RIS

TY  - JOUR
TI  - Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.
AU  - Lund N
AU  - Wieboldt H
AU  - Fischer L
AU  - Muschol N
AU  - Braun F
AU  - Huber T
AU  - Sorriento D
AU  - Iaccarino G
AU  - Müllerleile K
AU  - Tahir E
AU  - Adam G
AU  - Kirchhof P
AU  - Fabritz L
AU  - Patten M
PY  - 2024
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2024.1355033
UR  - https://doi.org/10.3389/fcvm.2024.1355033
ER  - 

APA

N, L., H, W., L, F., N, M., F, B., T, H., D, S., G, I., K, M., E, T., G, A., P, K., L, F., & M, P. (2024). Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2024.1355033

Source records